This opportunity is no longer accepting applications.
grant PAR-22-186
Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
This grant supports research on transgender individuals to explore how gender reassignment interventions (like hormones, drugs, and surgeries) affect their biology, immune system, and vulnerability to HIV and other sexually transmitted infections.
The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their im…
Funding Source
Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases
Program: SBIR
Awards & funding
Award Ceiling: $275,000
Award Amount: $275,000
Dates
Opportunity Released: May 19, 2022
Open for Submission: May 19, 2022
Submission Deadline: December 7, 2024
Application Window Closes: December 7, 2024
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers